Podcasts about medical science

With Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia, Georgia Sarquella Brugada, Hospital Sant Joan de Deu, Barcelona - Spain and Giulio Conte, Cardiocentro Ticino Institute, Lugano - Switzerland. In this podcast, Georgia Sarquella and Giulio Conte discuss the EHRA Clinical Consensus Statement on ultra-rare inherited arrhythmia syndromes, exploring the challenges of diagnosis, genetics, foetal electrophysiology, and lifelong management from childhood to adulthood.

In this episode, we spoke with Arndt Vogel, MD, a faculty member at the University of Toronto Institute of Medical Science, a scientist at the Toronto General Hospital Research Institute, and a medical oncologist at the UHN–Princess Margaret Cancer Centre in Canada.In our exclusive interview, Dr Vogel highlighted the rationale and growing evidence for sequential FGFR inhibition in FGFR2 fusion–positive cholangiocarcinoma, explaining that on-target resistance mutations and the differing binding properties of agents like pemigatinib (Pemazyre), futibatinib (Lytgobi), and the more selective tinengotinib (TT-00420) support using these drugs in sequence, although he emphasized that treatment decisions remain biomarker-informed rather than biomarker-guided. He also stressed the importance of early, RNA-based next-generation sequencing, the emerging role of circulating tumor DNA in capturing polyclonal resistance, and his anticipation of forthcoming phase 3 tinengotinib data.

Want to share your feedback? Send us a message!Selma Saad Merouwe, Ph.D., Speech-Language Pathologist, researcher, and Assistant Professor at Saint Joseph University of Beirut, joins host Sara MacIntyre, M.A., CCC-SLP, BCS-SCF, to discuss her recent study, “Is One Language Enough? Assessing Overt Stuttering Severity in Bilingual Children,” co-authored with Raymond Bertram, Ph.D., and Kurt Eggers, Ph.D. Selma begins by providing background on bilingualism and stuttering, including what previous research has suggested about how stuttering may present across languages and some of the challenges clinicians face when assessing bilingual children who stutter.She then shares more about the distinctive early multilingual language-learning landscape in Lebanon and how it provided an opportunity to explore early bilingualism and stuttering in unique ways. Selma walks listeners through the study design and findings, including what the results may tell us about assessing overt stuttering severity across languages when considering early multilingual language learners. The episode concludes with clinical implications, strengths and limitations of the current research, and areas for continued investigation aimed at supporting more evidence-based and culturally responsive assessment of bilingual children who stutter.Merouwe SS, Bertram R, Eggers K. Is One Language Enough? Assessing Overt Stuttering Severity in Bilingual Children. Folia Phoniatr Logop. 2026 May 8:1-14. doi: 10.1159/000552443. Epub ahead of print. PMID: 42102010.https://pubmed.ncbi.nlm.nih.gov/42102010/Selma Saad Merouwe, Ph.D., is an assistant professor at Saint Joseph University of Beirut and a researcher at the Speech Therapy Research Lab. With nearly two decades of experience spanning clinical practice, teaching, and research, her work focuses primarily on stuttering, cluttering, and language disorders. She is a European Stuttering Specialist (certified in 2018) and holds two doctoral degrees in complementary fields: a PhD in Social and Behavioral Sciences from the University of Turku (Finland) and a PhD in Biological and Medical Sciences from Saint Joseph University of Beirut. Her research explores the relationship between stuttering and bilingualism, as well as the cultural and linguistic adaptation of assessment tools for the Lebanese context. Selma is also affiliated with Ghent University (Belgium) as a postdoctoral researcher at the Stuttering Research Group. She collaborates with international research teams on projects examining stuttering across languages and cultures, with the shared aim of supporting assessment and intervention practices that are both evidence-based and culturally responsive. Alongside her academic role, she co-founded Terap Clinics, where she works with children, adolescents, and adults who present with stuttering, cluttering and language disorders. She is actively involved in professional service and advocacy, serving as Head of the Stuttering Committee at the Lebanese Association of Speech and Language Therapists, a member of the Practice Committee of the World Stuttering and Cluttering Organization (WSCO), and Lebanon's representative in the International Cluttering Association (ICA).

In today's episode, we spoke with Elias Jabbour, MD, and Dennis Kim, MD. Dr Jabbour is a professor of Leukemia at The University of Texas MD Anderson Cancer Center in Houston. Dr Kim is an associate professor at the Institute of Medical Science at the University of Toronto in Canada.In our exclusive interview, Drs Jabbour and Kim discussed the third-generation TKI olverembatinib (HQP1351), how it works, and its advantages compared with other treatment options for chronic myeloid leukemia and acute lymphoblastic leukemia. Additionally, the 2 experts overviewed data for the investigational TKI that came out of the 2026 ASCO Annual Meeting like the phase 1b HQP1351CU101 trial (NCT04260022) and a single-arm, multicenter study (ChiCTR2200061655), as well as the next steps for olverembatinib like in the ongoing phase 3 POLARIS-2 (NCT06423911) trial.

Why does one person become critically ill from a virus while another person exposed to the same microbe remains completely healthy? This is the "infection enigma," and Jean-Laurent Casanova, MD, PhD, has spent his career trying to solve it. A French pediatrician and immunologist, Casanova is the winner of Northwestern University's 2026 Mechthild Esser Nemmers Prize in Medical Science. In this episode, Casanova discusses his paradigm-shifting discoveries and what they reveal about immunity, genetic predisposition and why some people develop life-threatening infections while others do not. 

A stark advert picturing a gravestone chiselled with ‘AIDS: DON'T DIE OF IGNORANCE' captured the horror of this disease in the 1980s. Now, for HIV-infected people able to access anti-retroviral therapies, life expectancy is normal.How were these amazing medicines developed and how have they transformed lives? Why is it so difficult to eradicate HIV or to develop a vaccine to prevent infection? What does the future hold in the quest to stop the global scourge of AIDS?This lecture was recorded by Matt Higgins  on the 16th of September 2026Matt studied natural sciences at Christ's College in the University of Cambridge and a Ph.D. in structural biology at the Laboratory of Molecular Biology. He started his research group with a Royal Society University Research Fellowship in 2005 and moved to the University of Oxford in 2010. He is currently the E. P. Abraham Professor of Structural Biology and a Professorial Fellow at Merton College, Oxford. He is a Fellow of the Academy of Medical Sciences and a member of the European Molecular Biology Organisation.The transcript of the lecture is available from the Gresham College website: https://www.gresham.ac.uk/watch-now/hiv-pandemicGresham College has offered free public lectures for over 400 years, thanks to the generosity of our supporters. There are currently over 2,500 lectures free to access. We believe that everyone should have the opportunity to learn from some of the greatest minds. To support Gresham College's mission, please consider making a donation: https://www.gresham.ac.uk/get-involved/support-us/make-donation/donate-today Website:  https://gresham.ac.ukX: https://x.com/GreshamCollegeFacebook: https://facebook.com/greshamcollegeInstagram: https://instagram.com/greshamcollegeBluesky: https://bsky.app/profile/greshamcollege.bsky.social TikTok: https://www.tiktok.com/@greshamcollegeSupport Us: https://www.gresham.ac.uk/get-involved/support-us/make-donation/donate-todaySupport the show

Alcohol has spent the last 40 years bouncing between two health narratives: a little is good for your heart, or any amount is dangerous. The science doesn't really support either slogan.Dr. Tim Naimi has spent decades studying the health effects of alcohol and, just as importantly, why the research is so difficult to interpret. His read of the evidence is less dramatic but more useful: there's no good reason to start drinking for your health, very low intake may carry little measurable added risk, and risk rises as consumption does. Understanding why earlier studies made moderate drinking look protective helps explain a lot of the whiplashing headlines.Free course: Improve your metabolic healthGet our free email course on how glucose, nutrition, exercise, sleep, and measurement can help you build habits that support better energy and long-term health: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://levels.link/wnl⁠What We Cover:Why alcohol is a Group 1 carcinogen causally linked to at least seven cancersWhether small amounts of alcohol really protect your heartWhy researchers still don't have a definitive randomized trial of drinking and long-term healthHow the “sick quitter” problem, selection bias, and confounding made moderate drinkers look healthierWhy two major recent reviews of alcohol and health produced such different headlinesHow the risk changes with dose, including Naimi's estimate of a 1 in 25 lifetime risk of an alcohol-caused death at 14 drinks per weekWhy alcohol consumption is falling, and whether GLP-1 drugs could be contributing

In this week's episode, Blood editor Dr. James Griffin interviews Dr. Jianxiang Wang from the National Clinical Research Center for Blood Diseases and the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College in Tianjin, China, on his latest article published in Blood titled "Venetoclax plus pediatric regimen in adolescents and adults with Ph-negative acute lymphoblastic leukemia." In this prospective phase 2 study, 167 adolescents and adults (aged 14-60 years) with ND Ph− ALL received a course of venetoclax combined with pediatric-inspired chemotherapy, to determine the results of this treatment on MRD negativity.

In the first episode of season 5, we explore the bread and butter of implantable hearing devices: Bilateral cochlear implantation. Host Sofia Olaizola chats with Dr. Karen Gordon and Dr. Carly Anderson. Dr. Karen Gordon is a senior scientist and director of research at the Archie's Lab Cochlear Implant Lab. She is a professor in the Department of Otolaryngology and a graduate faculty member in the Institute of Medical Science at the University of Toronto. Dr. Karen Gordon will be featured in all of the episodes this season! Dr. Carly Anderson is a lecturer in neuroscience at Lancaster University who studies multimodal communication and plasticity. This episode looks at the beginnings of cochlear implants and how research shapes our current approaches to surgery, rehabilitation, language development and auditory processing. Sofia, who is completing her MSc in Audiology at Dalhousie University, brings a perspective of a bilaterally implanted user and shares her experiences with cochlear implants.    Transcript of S5E1 Dr. Carly Anderson at Lancaster University   Previous episodes featuring Dr. Carly Anderson: #3: Insights from Early Career Hearing Researchers with Dr. Hannah Stewart and Dr. Carly Anderson  Recorded on Oct 10, 2025 Produced by Maria Khan Music composed and performed by Dr. Blake Papsin, Otolaryngologist-in-Chief, Department of Otolaryngology (Head and Neck Surgery) at the Hospital for Sick Children 

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

Something different for the podcast today: a live event. It's the inaugural BMJ lecture, in partnership with the Academy of Medical Sciences and hosted at the historic Royal Academy of Arts. We want to talk about the big issues facing healthcare professionals around the world - and we're starting with one of the biggest: how do we make decisions in the face of real risk and genuine uncertainty? Well, who better to talk through those big questions than the man who had to try to navigate those risks and uncertainties during the pandemic? Chris Whitty is England's Chief Medical Officer and Chief Medical Adviser to the UK Government, advising on all aspects of healthcare. He is also a professor of public health at the London School of Hygiene and Tropical Medicine, where he was director of their Malaria Centre. In his lecture, Professor Whitty argues that medical training must better prepare doctors to manage risk, highlighting that "higher risk decisions, and accountability for these, have moved to later in training", causing a "substantial and sudden step up" in risk for new consultants. He acknowledges AI's potential to speed up clinical diagnostics, but warns against public-facing AI tools that present diagnoses with false certainty while ignoring medical risk and uncertainty. Read the related Opinion article: "We must be more systematic about risk holding throughout doctors' careers" This recording is available to view on YouTube.

What if the symptoms you've learned to live with are actually your body trying to tell you something? In this episode, I am joined by VJ Hamilton, The Autoimmunity Nutritionist, to explore what can happen when we slowly drift away from optimal health and how we can begin finding our way back. We also dive into nutrient deficiencies, inflammation, gut and cellular health, nervous system regulation, and why rebuilding your health doesn't have to happen all at once.You're going to love this conversation, and you're going to want to share it with everyone you care about who also desires to look and feel their best too!Learn more about VJ Hamilton:VJ Hamilton, also known as The Autoimmunity Nutritionist, is the founder of The Autoimmune Nutrition Clinic and a Registered Nutritionist, specialising in reversing hair loss, particularly alopecia areata, and other autoimmune-related conditions. With a Medical Science degree (BSc) in Biochemistry & Immunology and certification from the Institute for Functional Medicine, VJ combines scientific expertise with lived experience to deliver evidence-based, personalised therapies.After losing significant amounts of hair to alopecia areata in her 20s, alongside battling psoriasis and post-viral chronic fatigue syndrome, VJ rebuilt her health and restored her hair naturally—remaining symptom-free for over nine years. Today, she helps clients worldwide through her signature programmes and her membership, The Root RESET™ Circle, guiding them to address root causes, calm inflammation, and promote healthy, lasting hair growth.VJ's expertise has been featured in Vogue, GQ, Cosmopolitan, and The Telegraph. She also hosts The Autoimmune Reset® Podcast, where she shares practical strategies for hair regrowth, skin health, and immune resilience.Connect with VJ Hamilton:Website: https://theautoimmunitynutritionist.com/Download the The Autoimmunity Recovery Plan: https://vjhamilton.kartra.com/page/TheAutoimmunityRecoveryPlanStep into your Radiance Sanctuary in the Membership https://www.theschoolofradiance.com/membershipFor more resources related to today's episode, click here for the podcast episode page: https://www.theschoolofradiance.com/podcasts Follow Rachel Varga Official on Instagram: https://www.instagram.com/rachelvargaofficial/ —Catch full episodes of The School of Radiance Podcast here on YouTube https://www.youtube.com/@RachelVargaOfficial —Subscribe to the YouTube channel here: https://www.youtube.com/@RachelVargaOfficial —Follow me here:Instagram: https://www.instagram.com/rachelvargaofficial/ Facebook: https://www.instagram.com/rachelvargaofficial/ Website: https://www.theschoolofradiance.com —FREE STUFF: Download my FREE Skincare Checklist, sign up for my FREE 30 minute biohack your way to clear skin and slowing aging training now, and my newsletter for promos and exclusive events just for you! https://www.theschoolofradiance.com/freebiesEveryone gets one FREE call! Book your free 15-minute call with Rachel Varga to see which options will help you achieve your skin radiance goals! https://rachelvarga.as.me/YourPersonalizedRadianceConsultation —Looking for Skincare products, Tutorials, booking YOUR private One-on-One, and the deep dive Radiance Membership?SHOP skincare: https://alwaysradiantskinshop.comBOOK your private One-on-One: https://rachelvarga.as.me/Initialconsultation REGISTER for Tutorials and/or Membership: https://theschoolofradiance.com As a disclaimer, please note that the information shared in this podcast and interview is not to be taken as medical advice, and it's always important to consult with your physician before making any lifestyle changes. Rachel disclaims any responsibility for inaccurate credentials of guests or information used that may cause harm.Thank you for tuning in to this episode of The School of Radiance with Rachel Varga (formerly The Rachel Varga Podcast and The Always Radiant Skin Podcast)!Rachel Vargainfo@theschoolofradiance.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

William B. Coley started using a bacterial infection to treat cancers in the late 19th century, one of the earliest uses of immunotherapy. Research: Ahuja, Sana and Sufian Zaheer. “The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives.” Korean Journal of Clinical Oncology 2024; 20(2): 51-73. DOI: https://doi.org/10.14216/kjco.24009 Atkins, Douglas. “Helen Coley Nauts: Advocate for Immunotherapy.” National Library of Medicine. 4/19/2016. https://circulatingnow.nlm.nih.gov/2016/04/19/helen-coley-nauts-advocate-for-immunotherapy/ Cancer Research Institute. “The History of Cancer Immunotherapy.” Coley, William B. “Therapeutic Value of the Mixed Toxins of the Streptococcus of Erysipelas and Bacillus Prodigiosus in the Treatment of Inoperable Malignant Tumors. With a Report of 160 Cases.” American Journal of the Medical Sciences. September 1896. College of Physicians of Philadelphia. “Cancer Vaccines and Immunotherapy.” History of Vaccines. https://historyofvaccines.org/vaccines-101/future-immunization/cancer-vaccines-and-immunotherapy/ Colley, William B. “The Treatment of Inoperable Sarcoma by Bacterial Toxins (the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus).” Reprinted from the “ Proceedings of the Royal Society of Medicine,” November, 1909. London. John Bale, Sons & Danielsson, LTD. 1909. https://archive.org/details/b22425949/mode/1up Decker WK, da Silva RF, Sanabria MH, Angelo LS, Guimarães F, Burt BM, Kheradmand F and Paust S (2017) Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models. Front. Immunol. 8:829. doi: 10.3389/fimmu.2017.00829 Devaraja, K. et al. “Coley’s Toxin to First Approved Therapeutic Vaccine—A Brief Historical Account in the Progression of Immunobiology-Based Cancer Treatment.” Biomedicines 2024, 12, 2746. https://doi.org/10.3390/biomedicines12122746 Dobosz, Paula and Tomasz Dzieciatkowski.” The Intriguing History of Cancer Immunotherapy. Frontiers in Immunology. 12/17/2019. doi: 10.3389/fimmu.2019.02965 Hall, Stephen S. “A Commotion in the Blood: Life, Death, and the Immune System.” Henry Holt and Company. Excerpted at New York Times. https://archive.nytimes.com/www.nytimes.com/books/first/h/hall-commotion.html Harutyunyan, Mariam. “How William Coley Became The Father of Cancer Immunotherapy.” OncoDaily Magazine. 7/31/2026. https://oncodaily.com/magazine/william-coley-549446 Hiroaki Ikeda, Cancer immunotherapy in progress—an overview of the past 130 years, International Immunology, Volume 37, Issue 5, May 2025, Pages 253–260, https://doi.org/10.1093/intimm/dxaf002 Journal of the American Medical Association. “Erysipelas Toxins in the Treatment of Malignant Tumors.” 10/27/1894. Journal of the American Medical Association. “The Failure of the Erysipelas Toxins.” Vol 23 Iss 24. 12/15/1894. Kokolus, Katie. “The History of Immunotherapy: Toxins, Targets & T Cells.” LabRoots. 10/18/2021. https://www.labroots.com/trending/cancer/21449/history-immunotherapy-toxins-targets-cells?srsltid=AfmBOooP1eoVP2LbWKR5m-HLu1PSBFhOyPH1jSJWWcxvyK6EA4-hBu47 Levine, David B. “The Hospital for the Ruptured and Crippled: William Bradley Coley, third Surgeon-in-Chief 1925-1933.” HSS journal : the musculoskeletal journal of Hospital for Special Surgery vol. 4,1 (2008): 1-9. doi:10.1007/s11420-007-9063-2 McCarthy, Edward F. “The Toxins of William B. Coley and the Treatment of Bone and Soft-tissue Sarcomas.” The Iowa Orthopaedic Journal. Vol. 26. Memorial Sloan Kettering Cancer Center. “MSK Immunotherapy — Timeline of Progress.” https://www.mskcc.org/timeline/immunotherapy-msk National Library of Medicine. “Harnessing the Power of You: The History of Immunotherapy.” https://www.nlm.nih.gov/exhibition/the-history-of-immunotherapy/index.html Nauts, Helen Coley. “Coley’s Toxins – The First Century.” Townsend Letter for Doctors and Patients. June 2004. Nawrat, Allie. “Charting the history of immunotherapy, cancer treatment’s fourth pillar.” Pharmaceutical Technology. 7/28/2020. https://www.pharmaceutical-technology.com/features/charting-the-history-of-immunotherapy-cancer-treatments-fourth-pillar/?cf-view&cf-closed Oiseth SJ, Aziz MS. “Cancer immunotherapy: a brief review of the history, possibilities, and challenges ahead.” J Cancer Metastasis Treat. 2017;3:250-61. http://dx.doi.org/10.20517/2394-4722.2017.41 Tontonoz, Matthew. “What Ever Happened to Coley’s Toxins?.” Cancer Research Institute. 4/2/2015. https://www.cancerresearch.org/blog/what-ever-happened-to-coleys-toxins See omnystudio.com/listener for privacy information.

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

BUFFALO, NY – August 31, 2026 – A new #editorial was published in Volume 17 of Oncotarget on June 8, 2026, titled “Tumor infiltrating lymphocyte (TIL) therapy for treating the solid tumors: Challenges and future perspectives.” The editorial was led by first and corresponding author Bhartendra Sharma from Mahatma Gandhi University of Medical Sciences and Technology, Jaipur, Rajasthan, India, along with co-authors Sukhbir Kaur, Vikas Sharma and Sanjay Soni. Tumor-infiltrating lymphocyte (TIL) therapy is a form of adoptive cellular therapy that uses immune cells naturally present within tumors to attack cancer. Unlike chimeric antigen receptor (CAR) T-cell therapy, which genetically modifies a patient's T cells to recognize specific tumor antigens and has achieved its greatest success in hematological malignancies, TIL therapy has shown potential in several types of solid tumors. The approach has a history spanning more than four decades. Steven Rosenberg first isolated TILs from a mouse tumor in 1982, and subsequent experiments demonstrated antitumor effects when TILs were combined with cyclophosphamide and interleukin-2 (IL-2). In 1988, Rosenberg and colleagues reported favorable clinical outcomes after administering TIL therapy to patients with metastatic melanoma. Full press release - https://www.oncotarget.com/news/pr/tumor-infiltrating-lymphocyte-therapy-offers-a-promising-approach-for-treating-solid-tumors/ DOI - https://doi.org/10.18632/oncotarget.28883 Correspondence to - Bhartendra Sharma - bhartendrasharma@mgumst.org Intro video - https://www.youtube.com/watch?v=QAr_R4WCJfk Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28883 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, tumor infiltrating lymphocytes, solid tumors, adoptive cellular therapy, immunotherapy To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us on social media: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Send us Fan Mail"Going on the path of the desert is to avoid the false hope                            that if I don't find what I want, I will try my best."In this episode, which begins with this beautiful verse by Saadi, we have tried our best to talk about one of the most serious challenges facing the country's health sector today:Unsupported advertising!When anyone, with any level of literacy, experience, and expertise, allows themselves to write a prescription for the health of others, advertise a product, and deliver it to the consumer, the market for health products, especially those with apparent herbal names, is no longer limited to pharmacies.Then, the tragedy of people's health becomes the tragedy of a population that, with closed eyes, has entrusted their bodies, their futures, and the lives of their children to Instagram ads, discredited claims on social media, and advice from "wise men, grocers, bed-makers, and butchers."And perhaps that's why I chose the title "The Sparrowhawk" for these two episodes, 84 and 85."Gandeshkak Ashi-Mashi" is not just a popular Iranian song, it is a metaphor for the victims of unsupported propaganda of the present day, whose stories are heard in this episode from the mouths of officials and based on reliable evidence.The story of this episode                             is the story of choices that are sometimes made without knowledge, without evidence, and without oversight, and for which a heavy price is paid.

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

Is Burnout an Individual or Organisational Problem? (Feed Drop: Fried: The Burnout Podcast) In this special summer feed drop, we're taking a short break from our regular format to bring you a conversation from a show we genuinely love and listen to: Fried: The Burnout Podcast, hosted by the brilliant Cait Donovan! In this episode, Cait puts our very own Chartered Occupational Psychologist, Leanne Elliott, in the hot seat. They dive deep into the messy, nuanced reality of workplace culture, systemic stress, and employee wellbeing. Cait doesn't let Leanne off lightly, challenging her on everything from the validity of psychometric tests to where manager training fails and where individual responsibility ends and organizational responsibility begins. If you've ever wondered why workplace stress persists despite wellness initiatives, or how we can build truly supportive work environments, this honest, no-bullshit discussion is for you.

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

Disclaimer: In this episode, Alastair shares his enthusiasm and passion for postbiotics. Please note that while this is a rapidly evolving area of microbiome research, the scientific evidence is still building. The Microbiome Medics team advises that there is currently insufficient evidence to support specific health claims regarding postbiotics. We have enclosed some high-quality references below for listeners interested in further reading.What are postbiotics, and why might they be the next massive breakthrough in gut health? In this episode of the Microbiome Medics Podcast, Dr. Sheena Fraser is joined by Alastair Jessel, founder of The Postbiotic Company (AYA BIOME™), for an eye-opening dive into the world of post-fermentation microbial science.Using a clever "beer factory" analogy, Alastair breaks down exactly how postbiotics differ from prebiotics and live probiotics, explaining why these stable, inanimate metabolites might bypass the common pitfalls of live probiotic supplements, like dying on the shelf or in stomach acid. The conversation explores the patented fermentation of turmeric, sharing compelling insights from clinical trials regarding inflammation, weight management, and systemic health, alongside striking anecdotal evidence for skin conditions like rosacea.Dr. Fraser grounds the discussion with clinical nuance, emphasizing the foundational importance of a whole-food, plant-based diet and natural fermented foods, while exploring how targeted postbiotic supplements could support patients recovering from antibiotic use or managing chronic metabolic issues.Tune in to learn:The fundamental differences between prebiotics, probiotics, and postbiotics.Why shelf stability and bioavailability are the biggest hurdles for gut supplements.The clinical evidence behind fermented turmeric and its 550+ active metabolites.The potential role of postbiotics in post-antibiotic gut recovery, skin health, and metabolic function.Why Dr. Fraser advocates for a "food first" approach alongside emerging microbiome therapies.(Guest Info: Alastair Jessel is the founder of AYA BIOME™ and publishes commentary on the gut health industry via his Substack, @amanofkent.)Scientific References & Further Reading:Braga, J. D., et al. (2024). Gamma-aminobutyric acid as a potential postbiotic mediator in the gut-brain axis. Science of Food, 8(16).Higova, E. (2024). Postbiotics as metabolites and their biotherapeutic potential. International Journal of Medical Sciences, 25, 5441.Liang, B., & Xing, D. (2023). The current and future perspectives of postbiotics. Probiotics and Antimicrobial Proteins.Ma, L., et al. (2023). Postbiotics in human health. Nutrients, 15, 291.The Postbiotic Company. Research, Clinical Studies & Trials.This podcast is brought to you in collaboration with the British Society of Lifestyle Medicine.Disclaimer: The content in this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your doctor or qualified healthcare provider. Never disregard professional medical advice or delay in seeking it because of something you have heard on this podcast.

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

Women regularly hold leadership roles in stats departments at universities and in major statistical organizations, but it wasn't so long ago that women had to fight to be included. At one point, women faculty had to climb through the windows of the faculty club at Berkeley to attend meetings there; the stories of the struggles of women to be accepted in the profession aren't always visible. But one scholar is working to ensure those stories aren't forgotten. That's the focus of this episode of Stats and Stories with guest Amanda Golbeck.  Amanda Golbeck is the Associate Dean for Academic Affairs in the College of Public Health at the University of Arkansas for Medical Sciences, where she's also a professor of biostatistics. Golbeck's known for her work on health numeracy, demography, and human intervention trials, but she's also known for her work on statistical narrative and for the biographies she's written. In 2025, Golbeck published Florence Nightingale David: A Passionate Probabilist, Statistician, Historian, and Leader, and in 2017, Equivalence: Elizabeth L. Scott at Berkeley. In 2016, Golbeck received the Elizabeth L. Scott Award from the Committee of Presidents of Statistical Societies for her outstanding efforts in enhancing the status of women and minorities, fostering new leadership opportunities for women and men, promoting diversity at all levels, and advocating for a more inclusive, open, and supportive atmosphere in the statistical sciences.

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

Have you ever wondered how a child's ability to manage their emotions and impulses might shape their later mental health? And, what if one of the most important predictors isn't about how clever they are, but how well regulated they are on the inside? This episode of the Mind the Kids podcast features Lilja Jónsdóttir, a PhD student at the Department of Psychology at Uppsala University, Sweden, who will shortly take up a postdoctoral research position in child and adolescent psychiatry at Uppsala's Department of Medical Sciences. Hosted by Mark Tebbs, the conversation explores her paper, Examining Early Inhibitory Control and Emotional Regulation as Predictors of Childhood Internalizing and Externalizing Problems: A Longitudinal Study, co-authored with her supervisor Professor Karen Brocki, co-supervisors Dr. Matilda Frick and Dr. Andreas Frick of Stockholm University, and fellow PhD researcher Emma Heemann.The discussion unpacks the hierarchical development of self-regulation, examining how simpler skills such as inhibitory control — the ability to override an automatic impulse, illustrated through the classic marshmallow test — feed into more complex abilities like emotion regulation. Drawing on data from the long-running Effect Project, a longitudinal study following 94 typically developing children in Uppsala from infancy, Lilja explains how inhibitory control was measured at age four using the day-night Stroop task, emotion regulation was assessed at age six via validated parent-report measures, and internalizing and externalizing problems were captured at nine to ten years using the Strengths and Difficulties Questionnaire.Contrary to prior research and theoretical expectations, the study found no link between early inhibitory control and later emotion regulation or behavioural outcomes. Instead, emotion regulation at age six emerged as a robust, transdiagnostic predictor of both internalizing problems (such as worry and withdrawal) and externalizing problems (such as impulsivity and defiance) three to four years later — a finding that held even within a relatively advantaged community sample, strengthening the case for universal, early support.This conversation is essential listening for clinicians, educators, and parents interested in child development, self-regulation, and early intervention. Lilja discusses the importance of co-regulation between caregivers and children, promising directions for emotion-regulation-focused support, and why publishing null results — such as the absence of an inhibitory control effect here — matters for advancing the field.Read the JCPP Advances paper 'Examining early inhibitory control and emotion regulation as predictors of childhood internalizing and externalizing problems: A longitudinal study'Lilja K. Jónsdóttir, Matilda A. Frick, Andreas Frick, Emma J. Heeman, Karin C. BrockiFirst published: 07 January 2026 https://doi.org/10.1002/jcv2.70093Get a free CPD/CME certificate for listening to this podcast by registering for a FREE ACAMH Learn account at https://bit.ly/4fF4BBWVisit https://www.acamh.orgFacebook and LinkedIn search / ACAMHInstagram https://www.instagram.com/assoc.camhBluesky https://bsky.app/profile/acamh.bsky.socialX https://x.com/acamh

With Gerhard Hindricks, Charite University Hospital, Berlin - Germany, Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia and Micaela Ebert, Heart Center,  University Hospital Dresden, Dresden - Germany. This podcast will tackle how to prevent, manage and learn from complications in EP, while addressing teamwork, communication and the emotional impact on physicians and teams.

Should you lose weight or have your knee replaced? On this week's episode of Joint Action, Professor Marius Henriksen joins Professor David Hunter to discuss the INKA randomised controlled trial, which set out to test whether an intensive dietary weight loss program could deliver results comparable to knee arthroplasty for people with knee osteoarthritis who are eligible for surgery.Professor Marius Henriksen is a clinical professor of physiotherapy at the Faculty of Health and Medical Sciences, Copenhagen University, and head of musculoskeletal research at the Parker Institute at Copenhagen University Hospital in Denmark. His primary research focus is clinical research in osteoarthritis, with an emphasis on non-pharmacological management including exercise and weight loss.RESOURCESJournal Article: Intensive diet or knee arthroplasty for severe knee osteoarthritis: The inka randomised trialCONNECT WITH USNaia Health: https://www.naiahealth.com.au/st-leonards-hubJoin one of our trials: https://www.osteoarthritisresearch.com.au/current-trialsInstagram: @ProfDavidHunterTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcastIf you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

In this episode of CURiE Conversations, host Dr. Jessica Schuster speaks with Dr. Veronia Fahmy and Dr. James S. Welsh about their published work, "Small-Cell Carcinoma of the Bladder With Concurrent High-Grade Prostate Cancer: A Case Report and Review of the Literature."The discussion explores the management of this rare synchronous malignancy, the rationale for bladder-preserving chemoradiotherapy, the role of hypofractionated radiation and the clinical decision to use MRI surveillance instead of prophylactic cranial irradiation. They also reflect on how reviewing the limited literature surrounding rare cancers helped guide treatment.Contemporary Updates: Radiotherapy Innovation & Evidence (CURiE) is the official publication platform of the American College of Radiation Oncology through the Cureus Journal of Medical Science. Read the full article here: https://www.cureus.com/articles/502342-small-cell-carcinoma-of-the-bladder-with-concurrent-high-grade-prostate-cancer-a-case-report-and-review-of-the-literature

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

Several years ago, in 2016, we told a story about Amy Pearl. For as long as she could remember, Amy loved meat in all its glorious cuts and marbled flavors. And then one day, for seemingly no reason, her body wouldn't tolerate it.  No steaks. No brisket. No weenies. It made no sense: why couldn't she eat something that she had routinely enjoyed for decades?  It turned out Amy was not alone. And the answer to her mysterious allergy involved maps, a dancing lone star tick, and a very particular sugar called Alpha Gal.  In this update, we discover that our troubles with Alpha Gal go way beyond food. We go to NYU Langone Health hospital to see the second ever transplant of a kidney from a pig into a human, talk to some people at Revivicor, the company that bred the pig in question, and go back to Amy to find out what she thinks about this brave new world. The original episode was reported by Latif Nasser, and produced by Annie McEwen and Matt Kielty. Sound design and scoring from Dylan Keefe, Annie McEwen, and Matt Kielty. Mix by Dylan Keefe with Arianne Wack. The update was reported and produced by Sarah Qari. It was sound designed, scored, and mixed by Jeremy Bloom. LATERAL CUTS: How does a tick bit can cause a red meat allergy? - An episode from our friends over at Science Friday, who had a recent conversation with the researcher who discovered the connection, decades ago.   Support Radiolab by becoming a member today at Radiolab.org/donate.    Sign up for our newsletter!! It includes short essays, recommendations, and details about other ways to interact with the show. Signup (https://radiolab.org/newsletter)! Radiolab is supported by listeners like you. Support Radiolab by becoming a member of The Lab (https://members.radiolab.org/) today. Follow our show on Instagram, Twitter and Facebook @radiolab, and share your thoughts with us by emailing radiolab@wnyc.org.Leadership support for Radiolab's science programming is provided by the Simons Foundation and the John Templeton Foundation. Foundational support for Radiolab was provided by the Alfred P. Sloan Foundation. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Have you ever heard of Operation Paperclip? Originally called Operation Overcast, it was a top-secret U.S. operation that brought countless Nazi researchers, scientists, and engineers to America, where U.S. officials sought to utilize their research. Colin Heaton is an expert on Operation Paperclip and a historian and the president of CD Heaton Historical Consultants. Colin highlights some of the top Nazi minds that were brought to the U.S. during the operation, why they were coveted for their knowledge, and how they persecuted not just the Jewish people during the Holocaust, but also many Allied prisoners of war. Colin's newest book release, The Star of Africa, details the life of German Luftwaffe Captain Hans-Joachim Marseille. TAKEAWAYS Each Nazi researcher or scientist had his own motivations for their work Some German scientists wanted nothing to do with Hitler, but feared for their lives if they did not assist the Nazis Colin's deep interest in World War II history began during the 1970s, when he was reading a book about German fighter pilots Operation Paperclip was a huge secret, since recruiting foreign nationals for U.S. military work would have been prohibited

What happens when physicians become patients, teachers become storytellers, and medicine meets humanity? In this powerful episode of The Lebanese Physicians Podcast, I sit down with Dr. David Spiro, Professor and Chair of Emergency Medicine at the University of Arkansas for Medical Sciences and host of the Humed Podcast, to explore the emotional realities of practicing medicine. Dr. Spiro shares a deeply personal story from pediatric emergency medicine that shaped his career and discusses why storytelling is essential for physicians, patients, and healthcare professionals alike. Together, they examine physician wellness, burnout, compassion, resilience, leadership, medical education, and the importance of caring for healthcare workers while caring for patients. This thoughtful conversation also explores public health challenges, communication with families during difficult moments, the role of advocacy in medicine, and why sharing our stories can strengthen both healthcare professionals and the communities they serve. In this episode you'll learn about: Why storytelling is essential in medicine The emotional impact of caring for critically ill patients Physician burnout, resilience, and mental wellness Leading healthcare teams through difficult situations Building empathy in medical education The mission behind the Humed Podcast Finding purpose and meaning through medicine If you're a physician, medical student, healthcare professional, or simply interested in the human side of medicine, this conversation offers valuable insights into compassion, leadership, and healing.

In this week's episode, Rex Nelson sits down with the Chancellor of the University of Arkansas for Medical Sciences, Dr. Lowry Barnes. Barnes talks about his journey from starting medical school as a freshman to becoming the top executive for UAMS. Podcast on Apple, Spotify, and YouTube, or visit arkansasonline.com/podcast23 for an exclusive subscription offer available only to podcast listeners Chapters (00:00:14) - Southern Fried Podcast(00:01:08) - Arkansas orthopedic pioneer Dr. Banks Blackwell's story(00:05:57) - A message from North Pittock Hospital's first surgeon(00:08:34) - UAMS Orthopedics(00:09:31) - Interim Chancellor and the permanent role(00:11:33) - Some of the Changes at UAMS since my arrival(00:16:51) - UAMS supports rural hospitals(00:21:12) - Arkansas University System's Strategic Plan(00:26:48) - Dr. Lowry Barnes on His Drive to Make UAMS Better

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

Send us Fan MailRob Sambursky, MD, has more than 25 years of experience spanning the life sciences industry and clinical medicine. He is a fellowship-trained cornea specialist and currently serves as Chief Executive Officer of DefEYE, Inc.. Prior to joining DefEYE, Dr. Sambursky was one of the original founders of RPS Diagnostics and served as President and Chief Executive Officer of both RPS Diagnostics and Lumos Diagnostics. He led Lumos Diagnostics through its initialpublic offering on the Australian Securities Exchange. In addition, he was a founder and Executive Chairman of  Visus Therapeutics . Throughout his executive leadership roles, Dr. Sambursky also served as acting Chief Medical Officer for RPS Diagnostics, Lumos Diagnostics, and DefEYE.Dr. Sambursky currently serves as a strategic advisor to  Tenpoint Therapeutics  and is Board Chair of Advanced Ophthalmics, Inc. and Sustained Drug Delivery, Inc. He has extensive scientific and clinical expertise in ophthalmology, infectious disease, and medical sciences, and has served as an advisory board consultant to numerous ophthalmic therapeutic companies. Dr. Sambursky has authored dozens of patents and scientific publications, conceived a novel point-of-care diagnostic platform, and served as the clinical and regulatory lead supporting multiple international regulatory clearances and U.S. FDA 510(k) clearances with CLIA-waived designations. He has also played a key role in the successful commercialization of multiple diagnostic products in the United States and internationally.Dr. Sambursky is a practicing, board-certified ophthalmologist with fellowship training in corneal, external, and infectious disease. He earned a BA in Biology from Brown University, an MA in Medical Sciences with concentrations in biochemistry and microbiology from Boston University, and an MD from Boston University School of Medicine. He completed his medical internship at Mount Auburn Hospital, affiliated with Harvard Medical School, and completed both his ophthalmology residency and cornea fellowship at Wills Eye Hospital, where he also served as Co-Chief Resident.

Many U.S. states require HBV, blood testing, and vitamin K shots at, or soon after, birth. While these interventions may appear helpful. hospitals often provide no informed consent. They also neglect to inform parents they have a right to opt out, with some states going to lengths in order to conceal such opt-out forms. Some states lie about the procedures to coerce compliance. Medical staff are not above threatening to call police or CPS on parents, or prevent them from leaving the hospital, or conceal the baby until they acquiesce. In these cases, they are guilty of kidnapping and violating federal law. As for vitamin k, the shots actually have far more ingredients, some of which are known to kill infants according to the CDC. As for blood testing, most states store the blood without parental consent and give it to the military or private companies. *The is the FREE archive, which includes advertisements. If you want an ad-free experience, subscribe below.

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

For educational purposes only It's time to get superior results with us! Support your health & wellness journey with #Titan! Feel Better, Look Better & Perform Better with TitanMedical Center! HormoneOptimization #Health #Wellness #TitanMedicalCenter

For years, anyone who dared question the COVID vaccine was ridiculed, censored, and labeled a conspiracy theorist. Now, another crack has formed in the official narrative. On July 1st, the International Journal of Innovative Research in Medical Science published a study documenting what embalmers across five countries say they've been seeing since 2020: strange white fibrous structures unlike the clots many of them encountered during decades in the profession. According to the survey, a majority of embalmers reported observing them, and many say the phenomenon accelerated during the COVID era. Why does this matter? Because for years these reports were dismissed before they were ever seriously examined. Now they're in a peer reviewed scientific journal, raising questions that can no longer be waved away. Does this study prove the COVID vaccine caused these structures? No. It doesn't. But it does document consistent observations from embalmers in multiple countries and calls for independent scientific investigation into what these structures are, why they're appearing, and whether there's any connection to COVID infection, vaccination, or something else entirely. Science isn't supposed to shut down uncomfortable questions. It's supposed to investigate them. Today, we break down the newly published study from the International Journal of Innovative Research in Medical Science, why its publication on July 1st is such a significant moment, what the research actually says, what it doesn't say, and why Americans deserve honest answers instead of censorship. If public health officials expect the public to trust them again, transparency has to replace denial. That's exactly where this conversation begins. Your health is your responsibility. If you're looking for trusted physicians who aren't afraid to challenge the medical establishment, turn to The Wellness Company. From emergency medical kits to daily wellness solutions, they're focused on helping Americans take control of their health. Visit https://TWC.Health/Grant and use promo code GRANT to save 10%. See omnystudio.com/listener for privacy information.

Dr. Ashok K. Shetty is a University Distinguished Professor in the Department of Cell Biology and Genetics and Associate Director of the Institute for Regenerative Medicine at Texas A&M University, Naresh Vashisht College of Medicine. He is developing treatments for neurological and neurodegenerative disorders using stem cells and stem cell-derived products, such as extracellular vesicles. These are tiny vesicles secreted by stem cells that carry microRNAs and proteins. Once they make their way into the brain, they can induce beneficial changes in neural cells to improve brain function. Science takes up a lot of Ash's time, but when he's able to get a moment to himself, he enjoys spending time with family, cycling on a stationary bicycle, playing brain games like Sudoku, and going out to see movies at the theater. Ash earned his Ph.D. in Neuroscience from the All India Institute of Medical Sciences in New Delhi, and he completed postdoctoral research at Montana State University and Duke University. Afterward, he joined the faculty at Duke University in the Division of Neurosurgery. He joined the faculty at Texas A&M University College of Medicine in 2011. In 2024, he was honored with the University Distinguished Professor Award from Texas A&M University, and he has also received the College of Medicine's Senior Research Excellence Award. In addition, Ash is a Fellow of the American Association for the Advancement of Science and the American Society for Neural Transplantation and Repair. He has received the Research Career Scientist Award from the United States Department of Veterans Affairs, has been recognized among the "World's Top 1% of Scientists" across all scientific fields, and he was the 2025 honoree of Fast Company's World Changing Ideas. In this interview, Ash shares details about his life and his work in science.

Carlos Juan Finlay was a Cuban doctor who did a lot of work to understand the spread of Yellow Fever. But Walter Reed got most of the credit. Research: American Experience. “Carlos Finlay (1833-1915).” From The Great Fever. PBS. https://www.pbs.org/wgbh/americanexperience/features/fever-carlos-finlay/ Berenbrok, Dorothy E., "Latin Heritage Month. Carlos Juan Finlay: Outrageous, Courageous and Correct" (2015). Posters: Jefferson History. 3. https://jdc.jefferson.edu/jeffhistoryposters/3 "Carlos Juan Finlay." Encyclopedia of World Biography Online, Gale, 1998. Gale In Context: Opposing Viewpoints, link.gale.com/apps/doc/K1631002194/GPS?u=mlin_n_melpub&sid=bookmark-GPS&xid=bfeecc25. Accessed 29 Apr. 2026. Chaves-Carballo, Enrique. “Carlos J. Finlay: The mosquito man.” Hektoen International. 11/2/2020. https://hekint.org/2020/11/02/carlos-j-finlay-the-mosquito-man/ Corbitt, Duvon C. “Carlos J. Finlay, Cuban Physician.” The Hispanic American Historical Review, Vol. 45, No. 3 (Aug., 1965). Via JSTOR. https://www.jstor.org/stable/2511751 Del Regato, Juan A. “Carlos Juan Finlay (1833-1915).” Journal of Public Health Policy , 2001, Vol. 22, No. 1 (2001). Via JSTOR. https://www.jstor.org/stable/3343556 Faerstein, Eduardoa; Winkelstein, Warren Jrb. Carlos Juan Finlay: Rejected, Respected, and Right. Epidemiology 21(1):p 158, January 2010. | DOI: 10.1097/EDE.0b013e3181c308e0 Ferreira Moreno, Víctor Guillermo. “Evocation to the Dr. Carlos J. Finlay Barres on the centennial of his death.” Colombia medica (Cali, Colombia) vol. 47,1 63-6. 30 Mar. 2016 Finlay, Carlos J. “The Mosquito Hypothetically Considered as the Agent of Transmission of Yellow Fever.” Read before the Royal Academy of Medical, Physical and Natural Sciences Session of August 14th, 1881. https://archive.org/details/b33448541/page/590/mode/1up Finlay, Carlos Juan. “Trabajos selectos del Dr. Carlos J. Finlay. Selected papers of Dr. Carlos J. Finlay.” Habana. 1912. https://archive.org/details/trabajosselectos00finl Finlay, Charles. “Inoculations for Yellow Fever by Means of Contaminated Mosquitoes.” Published in The American Journal of the Medical Sciences, n.s. 102: 264-268, 1891. https://archive.org/details/b33445242/page/n4/mode/1up Finlay, Charles. “Yellow Fever: Its ‘Transmission by Means of the Culex Mosquito.” Published in The American Journal of the Medical Sciences, n.s. 92: 395-409, 1886. https://archive.org/details/b33435698/page/613/mode/1up Palmer, Steven. “A Cuban Scientist Between Empires: Peripheral Vision on Race and Tropical Medicine.” Canadian Journal of Latin American and Caribbean Studies / Revue canadienne desétudes latino-américaines et caraïbes, Vol. 35, No. 69, Special Issue: Landscapes of LatinAmerican Health, 1870-1970. Via JSTOR. https://www.jstor.org/stable/41800498 Spears, Ellen Griffith and Rosa López-Oceguera. “Carlos Juan Finlay, William Gorgas, and Walter Reed and the U.S. Army Yellow Fever Controversy: Competing Historical Memories.” Alabama Review The University of Alabama Press. Volume 74, Number 1, January 2021. https://doi.org/10.1353/ala.2021.0011 Stepan, Nancy. “The Interplay between Socio-Economic Factors and Medical Science: Yellow Fever Research, Cuba and the United States.” Social Studies of Science , Nov., 1978, Vol. 8, No. 4 (Nov., 1978). Via JSTOR. http://www.jstor.com/stable/284817 Thomas Jefferson University. “10 Notable Jefferson Alumni of the Past.” https://library.jefferson.edu/archives/exhibits/notable_alumni/juan_carlos_finlay.cfm Tone, John Lawrence. (2002) “How the mosquito (man) liberated Cuba.” History and Technology, 18:4, 277-308, DOI: 10.1080/07341512.2002.11417735 “Carlos J. Finlay.” 5/16/2023. https://www.unesco.org/en/prizes/carlos-j-finlay/about Woodall, Jack. "Yellow Fever." Infectious Diseases: In Context, edited by Brenda Wilmoth Lerner and K. Lee Lerner, vol. 2, Gale, 2008, pp. 925-931. In Context Series. Gale In Context: Opposing Viewpoints, link.gale.com/apps/doc/CX3045200265/GPS?u=mlin_n_melpub&sid=bookmark-GPS&xid=bf646a26. Accessed 29 Apr. 2026. See omnystudio.com/listener for privacy information.